Effects of insulin glargine versus metformin on glycemic variability, microvascular and beta-cell function in early type 2 diabetes.
about
Early Treatment with Basal Insulin Glargine in People with Type 2 Diabetes: Lessons from ORIGIN and Other Cardiovascular TrialsBasal insulin combined incretin mimetic therapy with glucagon-like protein 1 receptor agonists as an upcoming option in the treatment of type 2 diabetes: a practical guide to decision makingInsulin glargine effectively achieves glycemic control and improves insulin resistance in patients with early type 2 diabetes that exhibit a high risk for cardiovascular diseaseInfluence of insulin and glargine on outgrowth and number of circulating endothelial progenitor cells in type 2 diabetes patients: a partially double-blind, randomized, three-arm unicenter study.IDegLira Versus Alternative Intensification Strategies in Patients with Type 2 Diabetes Inadequately Controlled on Basal Insulin Therapy.A real-world study of the effect of timing of insulin initiation on outcomes in older medicare beneficiaries with type 2 diabetes mellitus.Clinical evidence for the earlier initiation of insulin therapy in type 2 diabetesSystematic review and meta-analysis of randomized clinical trials comparing efficacy and safety outcomes of insulin glargine with NPH insulin, premixed insulin preparations or with insulin detemir in type 2 diabetes mellitus.The effect of glargine versus glimepiride on pancreatic β-cell function in patients with type 2 diabetes uncontrolled on metformin monotherapy: open-label, randomized, controlled study.Distinct impacts of sleep-disordered breathing on glycemic variability in patients with and without diabetes mellitus.Initiating therapy in patients newly diagnosed with type 2 diabetes: Combination therapy vs a stepwise approach.Comparison of Glycemic Variability in Chinese T2DM Patients Treated with Exenatide or Insulin Glargine: A Randomized Controlled Trial.
P2860
Q26767164-E7802BA9-D04A-477F-AF58-92E02B9A00A3Q26992979-C7FF3A51-9E88-49CC-ACFE-7A8D6D36C78AQ33769611-54CF19AB-ACAE-4ECA-A265-B85E7A160054Q34333373-9579E75C-3BFE-44A1-BA50-4E30C48C2C4AQ36360100-7BC14C61-92B3-452C-B6E5-A2EAAC015AC0Q36971385-65E736E6-6CC6-42ED-B95A-7F22EE1E91BBQ38115799-AAFE7B47-8CC9-46BA-A923-96A4961DF0E1Q38317168-5CCA0FA2-9B5C-44BA-8434-1E166F40BCC1Q38442291-EBA60AFA-1D2A-451A-90AF-F22DE3114BD5Q47098884-F721E171-734A-4463-9A62-8655E7CC06E4Q48140061-E60D94ED-1B19-47EC-8AF0-D3454E7DBC64Q55347251-5B626AFA-3421-4CB2-8DD6-EFA54768580A
P2860
Effects of insulin glargine versus metformin on glycemic variability, microvascular and beta-cell function in early type 2 diabetes.
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Effects of insulin glargine ve ...... tion in early type 2 diabetes.
@ast
Effects of insulin glargine ve ...... tion in early type 2 diabetes.
@en
Effects of insulin glargine ve ...... tion in early type 2 diabetes.
@nl
type
label
Effects of insulin glargine ve ...... tion in early type 2 diabetes.
@ast
Effects of insulin glargine ve ...... tion in early type 2 diabetes.
@en
Effects of insulin glargine ve ...... tion in early type 2 diabetes.
@nl
prefLabel
Effects of insulin glargine ve ...... tion in early type 2 diabetes.
@ast
Effects of insulin glargine ve ...... tion in early type 2 diabetes.
@en
Effects of insulin glargine ve ...... tion in early type 2 diabetes.
@nl
P2093
P2860
P921
P1433
P1476
Effects of insulin glargine ve ...... tion in early type 2 diabetes.
@en
P2093
P2860
P2888
P304
P356
10.1007/S00592-012-0451-9
P577
2013-02-21T00:00:00Z
P5875
P6179
1001485495